As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and endoscopic response rates in patients with Crohn disease. The FDA has ...

The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday ...

Our analysis of options history for Eli Lilly LLY revealed 22 unusual trades. Delving into the details, we found 45% of traders were bullish, while 31% showed bearish tendencies. Out of all the ...

The medicines may not only suppress appetite but also help curb alcoholism and other addictions. Read more at straitstimes.com.

A recent study reveals many websites selling compounded versions of weight-loss drugs do not inform users of risks, often ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...